SEC Form 4 · accession 0001209191-17-036961
Armata Pharmaceuticals, Inc. · ARMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Igor Bilinsky
Officer — Chief Operating Officer
Period of report
May 30, 2017
Accepted (ET)
Jun 1, 2017 · 7:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921114
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.74 | May 30, 2017 | A | 87,161 | A | — | May 29, 2027 | Common Stock | 87,161 | 87,161 | D |
Explanation of responses
- F11/4th of the shares subject to the option vest on May 30, 2018. The remainder of the shares vest in equal monthly installments thereafter over the next three years.